Members Only

Events

IATDMCT 2013 13th International Congress of TDM & Clinical Toxicology
September 22 – 26, 2013
Salt Lake City, USA



12th International Congress of TDM & Clinical Toxicology
October 2 - 6, 2011
Stuttgart Germany
View photos from the Congress!

Login

Forgot Password

Our aims are:

  • Foster and promote education and research in therapeutic drug monitoring and clinical toxicology;

  • Improve the standards of practice and clinical interpretation of drug and toxic substance analyses and facilitate the delivery of interpretation through clinical pharmacokinetics and toxicokinetics for enhanced patient care;

  • Encourage cooperation with and among members of all professions concerned with TDM and clinical toxicology;

  • Encourage the effective application of therapeutic drug monitoring to optimize clinical drug use and maximize the clinical and economic benefits;

  • Encourage progress in clinical toxicology as a diagnostic tool and therapeutic aid for therapeutic drug overdoses, drug abuse, and exposure to environmental toxicants.


Application form (PDF) 

Definition of TDM


IATDMCT Needs You! - Click here!

Journal

Therapeutic Drug Monitoring is the official journal of IATDMCT

IATDMCT members have free on-line access to the journal Therapeutic Drug Monitoring.

Instructions for authors

IATDMCT Patsalos prize

IATDMCT PATSALOS PRIZE 

Professor Philip Patsalos and his wife Ellie, London, UK, set up the Patsalos Prize for the best TDM manuscript published in Therapeutic Drug Monitoring in a given two year calendar period and which will be awarded at the biannual IATDMCT Meeting.

Award of Prize
The Prize will be awarded at the next 5 IATDMCT congresses (2009, 2011, 2013, 2015, 2017 – although the prize may not be awarded at each occasion if a quality manuscript cannot be identified).

Selection Committee
IATDMCT President (chair), Prof. Patsalos, 2 Editors-in-Chiefs (Therapeutic Drug Monitoring), President-elect

Procedure for manuscript nomination and selection of winner
1. The two Editors-in Chief will first identify potential eligible manuscripts and make a proposal to the chairperson.
Selection criteria are: originality, conclusiveness, study design and performance, impact on science and practice (enhancing patient treatment/care), impact on future developments, global importance, etc.

2. The chairperson will check whether the first author (to whom the Prize will be awarded) is an active member of IATDMCT.
3. The chairperson will prepare a list of all eligible manuscripts and distribute the list to members of the Selection Committee for their consideration.
4. By conference call, a winner will be selected by "simple majority".

Which manuscripts are eligible for nomination
  • Full length original research manuscripts published during the two previous years of the year the prize is going to be awarded (i.e. for the prize awarded in 2009, papers published in 2007 and 2008 will be considered).
  • Exceptional contribution toward advancing knowledge in the field of TDM.

    Timeline
    The selection procedure will start at the beginning of the congress year and as soon as possible after the publication of the December issue of Therapeutic Drug Monitoring of the year before.

    Prize
    5.000 € plus an invitation to make a short presentation (Patsalos Lecture) at the Opening Ceremonies of the biannual IATDMCT congress.   In addition, IATDMCT offers a two-year free membership, anticipating active contributions to IATDMCT by the recipient.

     

     

    • Powered By Dragonfly IT Ltd.